Kidney stone risk is lowered by a class of diabetes medications: Study

The study shows that 'sodium-glucose contratransporter 2 (SGLT2) inhibitors can reduce the risk of acquiring kidney stones. | Health

Related Keywords

Massachusetts ,United States ,Julie Paik ,Division Of Renal Kidney Medicine At Brigham ,Division Of Pharmacoepidemiology ,Mass General Brigham ,Massachusetts General Hospital ,Kidney Stones ,Kidney Stones Symptoms ,Kidney Stones Treatment ,Kidney Stones Causes ,Kidney Stones Prevention ,Kidney Stones Signs ,